Similar Search Results

Early health economic evaluation of the future potential of next generation artificial vision systems for treating blindness in Germany

Schwander, Bjoern - In: Health economics review 4 (2014) 27, pp. 1-10

The next generation of artificial vision devices (AVDs), which is currently developed in pre-clinical settings, has the … potential to improve the vision of blind patients with retinitis pigmentosa (RP) in a manner that they will be categorized as … visual impaired but no more as blind. This unprecedented vision improvement will result in a mentionable quality of life gain …

Persistent link: https://www.econbiz.de/10010526936

Economic burden of blindness and visual impairment in Germany from a societal perspective : a cost-of-illness study

Chuvarayan, Yuliya; Finger, Robert P.; Köberlein-Neu, … - In: The European journal of health economics : HEPAC ; … 21 (2020) 1, pp. 115-127

Persistent link: https://www.econbiz.de/10012221642

Assessing the economic burden of vision loss and irreversible legal blindness in Spain : 2021-2030 : a societal perspective

Pablo, Luis; Garay-Aramburu, Gonzaga; García Layana, … - 2024

generate loss of vision and irreversible legal blindness is essential to understand the socioeconomic impact associated with …Objective To estimate the economic impact for the society, generated as a consequence of the onset of loss of vision … and irreversible legal blindness, for the main ophthalmologic diseases in Spain: glaucoma, diabetic retinopa- thy (DR …

Persistent link: https://www.econbiz.de/10015358454

Accessible tourism : how people with vision impairment and blindness experience tourism and "see" the invisible

Noghan, Nick; O'Connor, Peter; Sigala, Marianna - In: Tourism review 79 (2024) 7, pp. 1361-1366

Persistent link: https://www.econbiz.de/10015051909

Treating disability as an asset (not a limitation) : a critical examination of disability inclusion through social entrepreneurship

Mauksch, Stefanie; Dey, Pascal - In: Organization : the interdisciplinary journal of … 31 (2024) 4, pp. 624-644

Persistent link: https://www.econbiz.de/10014574593

How blockchain technology supports the business processes of clinical trials : a systematic review

Moatari-Kazerouni, Afrooz; Pai, Dinesh Ramdas; Chicas, … - In: Business process management journal 30 (2024) 2, pp. 388-410

Persistent link: https://www.econbiz.de/10015324153

Confounding and missing data in cost-effectiveness analysis : comparing different methods

Härkänen, Tommi; Maljanen, Timo; Lindfors, Olavi; … - In: Health economics review 3 (2013) 8, pp. 1-11

Introduction: Common approaches in cost-effectiveness analyses do not adjust for confounders. In nonrandomized studies this can result in biased results. Parametric models such as regression models are commonly applied to adjust for confounding, but there are several issues which need to be...

Persistent link: https://www.econbiz.de/10009783264

Artificial Insemination (AI) in swine and new product development (NPD) : evidence from Nigeria

Oniku, Ayodele Christopher; Bakare, Ibrahim A. O.; … - In: International journal of sustainable economies … 3 (2014) 1, pp. 26-38

Persistent link: https://www.econbiz.de/10010511511

Clinical trials for new drug development : optimal investment and application

Kouvelis, Panos; Milner, Joseph; Tian, Zhili - In: Manufacturing & service operations management : M & SOM 19 (2017) 3, pp. 437-452

Persistent link: https://www.econbiz.de/10011738562

Promoting innovation in small markets : evidence from the market for rare and intractable diseases

Iizuka, Toshiaki; Uchida, Gyo - In: Journal of health economics 54 (2017), pp. 56-65

Persistent link: https://www.econbiz.de/10011798595